| GRMN |
Report |
Net sales — Fitness (Q2 2026) |
BEAT |
pred ~$740M vs. cons $703.8M |
MEDIUM |
| GRMN |
Report |
Net sales — Outdoor (Q2 2026) |
MISS |
pred ~$420M vs. cons $483.0M |
HIGH |
| GRMN |
Report |
EPS — Diluted Operating (Q2 2026) |
BEAT |
pred ~$2.40 vs. cons $2.29 |
MEDIUM |
| GRMN |
Guide |
Revenue FY2026 (FY2026) |
UNCHANGED |
guide ~$8.0B maintained vs. cons $8.022B |
HIGH |
| GRMN |
Guide |
EPS Operating FY2026 (FY2026) |
LOWER |
guide ~$9.35 reiterated vs. cons $9.578 |
HIGH |
| GRMN |
Guide |
Outdoor H2 tone (H2 2026) |
UNCHANGED |
Reaffirmed but with caveats vs. 'stronger back half' language |
MEDIUM |
| GRMN |
Return |
Day-1 residual (stock − beta × S&P 500) |
-4.0% |
— |
MEDIUM |
| GRMN |
Return |
5-day cumulative residual |
-6.5% (FADE) |
FADE — Outdoor miss pulls H2 Outdoor estimates down; EPS guide reiteration at $9.35 forces sell-side cuts below current $9.578 consensus |
MEDIUM |